Skip to main content

Algert Global LLC

SEC CIK
0001275218
Latest filing
Aug 13, 2026

CRNX holding history

Crinetics Pharmaceuticals, Inc. in every 13F filed by Algert Global LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CRNX overviewAll 13F holders of CRNXFull Q2 2026 holdings

Shares (Q2 2026)
72,532
Value
$2.71M
% of portfolio
<0.1%
Quarters held
13
Since Q1 2022
Holdings of CRNX by Algert Global LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202672,532$2.71M<0.1%−25,270−25.8%ReducedHolders
Q1 202697,802$3.55M0.1%+97,802NewHolders
Q2 20250$00.0%−26,287−100.0%Sold outHolders
Q1 202526,287$881.7K<0.1%−2,490−8.7%ReducedHolders
Q4 202428,777$1.47M<0.1%−14,000−32.7%ReducedHolders
Q3 202442,777$2.19M0.1%+1,070+2.6%AddedHolders
Q2 202441,707$1.87M0.1%+6,667+19.0%AddedHolders
Q1 202435,040$1.64M0.1%+17,360+98.2%AddedHolders
Q4 202317,680$629.1K<0.1%+17,680NewHolders
Q2 20230$00.0%−18,710−100.0%Sold outHolders
Q1 202318,710$300.5K<0.1%+1,304+7.5%AddedHolders
Q4 202217,406$318.5K<0.1%00.0%UnchangedHolders
Q3 202217,406$342.0K<0.1%−2,673−13.3%ReducedHolders
Q2 202220,079$374.0K<0.1%−4,880−19.6%ReducedHolders
Q1 202224,959$548.0K<0.1%+24,959NewHolders